Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.

Anderwald CH, Tura A, Promintzer-Schifferl M, Prager G, Stadler M, Ludvik B, Esterbauer H, Bischof MG, Luger A, Pacini G, Krebs M.

Diabetes Care. 2012 Dec;35(12):2580-7. doi: 10.2337/dc12-0197. Epub 2012 Aug 24.

2.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Bojsen-Møller KN.

Dan Med J. 2015 Apr;62(4):B5057. Review.

PMID:
25872541
3.

Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.

Spector D, Shikora S.

Int J Clin Pract Suppl. 2010 Feb;(166):53-8. doi: 10.1111/j.1742-1241.2009.02279.x. Review.

PMID:
20377665
4.

Updates in weight loss surgery and gastrointestinal peptides.

Svane MS, Bojsen-Møller KN, Madsbad S, Holst JJ.

Curr Opin Endocrinol Diabetes Obes. 2015 Feb;22(1):21-8. doi: 10.1097/MED.0000000000000131. Review.

PMID:
25517025
5.

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.

Dirksen C, Jørgensen NB, Bojsen-Møller KN, Jacobsen SH, Hansen DL, Worm D, Holst JJ, Madsbad S.

Diabetologia. 2012 Jul;55(7):1890-901. doi: 10.1007/s00125-012-2556-7. Epub 2012 Apr 27. Review.

PMID:
22538359
6.

Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Chaudhry S, Bernardes M, Harris PE, Maffei A.

Minerva Endocrinol. 2016 Mar;41(1):43-56. Epub 2015 Oct 27. Review.

7.

Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery.

Mosinski JD, Kirwan JP.

Curr Diab Rep. 2016 Jun;16(6):50. doi: 10.1007/s11892-016-0747-1. Review.

8.

Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.

Kaska L, Sledzinski T, Chomiczewska A, Dettlaff-Pokora A, Swierczynski J.

World J Gastroenterol. 2016 Oct 21;22(39):8698-8719. Review.

9.

Hypoglycaemia after gastric bypass: mechanisms and treatment.

Ritz P, Vaurs C, Barigou M, Hanaire H.

Diabetes Obes Metab. 2016 Mar;18(3):217-23. doi: 10.1111/dom.12592. Epub 2016 Jan 5. Review.

PMID:
26508374
10.

Physiological adaptations following Roux-en-Y gastric bypass and the identification of targets for bariatric mimetic pharmacotherapy.

Docherty NG, Le Roux CW.

Curr Opin Pharmacol. 2015 Dec;25:23-9. doi: 10.1016/j.coph.2015.09.012. Epub 2015 Oct 20. Review.

PMID:
26496012
11.

GLP-1: a mediator of the beneficial metabolic effects of bariatric surgery?

Manning S, Pucci A, Batterham RL.

Physiology (Bethesda). 2015 Jan;30(1):50-62. doi: 10.1152/physiol.00027.2014. Review.

12.

Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission.

Castagneto Gissey L, Casella Mariolo J, Mingrone G.

Peptides. 2018 Feb;100:114-122. doi: 10.1016/j.peptides.2017.12.010. Review.

PMID:
29412812
13.

Post-Gastric Bypass Hypoglycemia.

Rariy CM, Rometo D, Korytkowski M.

Curr Diab Rep. 2016 Feb;16(2):19. doi: 10.1007/s11892-015-0711-5. Review.

PMID:
26868861
14.

Impact of Bariatric Surgery on Metabolic and Gut Microbiota Profile: a Systematic Review and Meta-analysis.

Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C, Zacharoulis D.

Obes Surg. 2017 May;27(5):1345-1357. doi: 10.1007/s11695-017-2595-8. Review.

PMID:
28265960
15.

Post-gastric bypass hypoglycaemia: a review.

Shantavasinkul PC, Torquati A, Corsino L.

Clin Endocrinol (Oxf). 2016 Jul;85(1):3-9. doi: 10.1111/cen.13033. Epub 2016 Feb 29. Review.

PMID:
26840207

Supplemental Content

Support Center